{
    "organizations": [],
    "uuid": "b993f25bbe8310883b31d87b851cb15a49cc267d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mimedx-announces-first-patients-ha/brief-mimedx-announces-first-patients-have-been-enrolled-in-the-phase-3-clinical-trial-of-amniofix-idUSASB0C11J",
    "ord_in_thread": 0,
    "title": "BRIEF-Mimedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of Amniofix",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 16, 2018 / 1:54 PM / Updated 8 minutes ago BRIEF-Mimedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of Amniofix Reuters Staff 1 Min Read \nJan 16 (Reuters) - Mimedx Group Inc: \n* MIMEDX ANNOUNCES FIRST PATIENTS HAVE BEEN ENROLLED IN THE PHASE 3 CLINICAL TRIAL OF AMNIOFIX® INJECTABLE IN PATIENTS WITH RECALCITRANT PLANTAR FASCIITIS PAIN \n* MIMEDX GROUP INC - ‍COMPANY PROJECTS FILING OF BLA RELATED TO PLANTAR FASCIITIS WILL BE IN 2020​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-16T15:53:00.000+02:00",
    "crawled": "2018-01-16T16:12:08.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "first",
        "patient",
        "enrolled",
        "phase",
        "clinical",
        "trial",
        "amniofix",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "mimedx",
        "group",
        "inc",
        "mimedx",
        "announces",
        "first",
        "patient",
        "enrolled",
        "phase",
        "clinical",
        "trial",
        "injectable",
        "patient",
        "recalcitrant",
        "plantar",
        "fasciitis",
        "pain",
        "mimedx",
        "group",
        "inc",
        "project",
        "filing",
        "bla",
        "related",
        "plantar",
        "fasciitis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}